Filiz Şen

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial”.

Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial

The Lancet Haematology(2020)10.1016/s2352-3026(20)30209-x

N/A

0.843DataRank · unranked

21 citations

Xiaoli Mi, Alexander Penson, Stella Paffenholz, Kelsey Alvarez, Allison Sigler +10 more

Leukemia cell of origin influences apoptotic priming and sensitivity to LSD1 inhibition

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.11.089060

N/A

0.312DataRank · unranked

7 citations

S. Haihua Chu, Aaron D. Goldberg, Salma Parvin, Richard P. Koche, Jacob L. Glass +22 more